Cargando…
EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death and lacks effective treatment options. Diagnostic endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) biopsies represent an appealing source of material for molecular analysis to inform targeted therapy,...
Autores principales: | Lundy, Joanne, Harris, Marion, Zalcberg, John, Zimet, Allan, Goldstein, David, Gebski, Val, Borsaru, Adina, Desmond, Christopher, Swan, Michael, Jenkins, Brendan J., Croagh, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696205/ https://www.ncbi.nlm.nih.gov/pubmed/34956889 http://dx.doi.org/10.3389/fonc.2021.770022 |
Ejemplares similares
-
Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer
por: Berry, William, et al.
Publicado: (2018) -
KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?
por: Shen, Henry, et al.
Publicado: (2022) -
EUS-FNA biopsy of parathyroid gland
por: Solonitsyn, Evgeny G., et al.
Publicado: (2021) -
The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2021) -
The difference in histological yield between 19G EUS-FNA and EUS-fine-needle biopsy needles
por: Ang, Tiing Leong, et al.
Publicado: (2019)